Compare American Well Corp (AMWL) vs Gitlab Inc (GTLB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
American Well Corp vs Gitlab Inc — how do they compare? American Well Corp trades at $9.61 (market cap $165.58M), while Gitlab Inc trades at $32.62 (market cap $5.48B). The key difference: Gitlab Inc is far larger — about 33.1× American Well Corp's market cap, and American Well Corp is trading nearer its 52-week high, Gitlab Inc nearer its low. Which is the better fit depends on your goals.
| AMWL | GTLB | |
|---|---|---|
Market Cap | $165.58M | $5.48B |
Sector | Health | Technology |
52-Week High | $9.91 | $51.04 |
52-Week Low | $3.78 | $19.42 |
Enterprise Value | -$9.66M | $4.22B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
GitLab (GTLB) trades at $32.42, down 4.25% today, but maintains a bullish technical outlook with strong moving average signals. The company shows impressive revenue growth, reaching $759 million in 2025, with consistent earnings beats in recent quarters. Analyst sentiment is mixed with 36.7% buy ratings, while the stock trades near consensus price target of $31.93. Recent news highlights GitLab's leadership in DevSecOps and strategic AI partnerships.
GitLab presents a growth story with strong market positioning but faces profitability challenges. The stock offers upside potential from AI-driven software demand and enterprise adoption, though high valuation multiples and negative cash flow pose risks. Investors should weigh the company's strategic position against its path to sustainable profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Gitlab Inc
GitLab Inc operates on an all-remote model. The company is a technology company whose primary offering is GitLab, a complete DevOps platform delivered as a single application. GitLab is used by a wide range of organizations. The company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Read more on GTLB →
